Cerebral phaeohyphomycosis caused by Cladophialophora bantiana in a patient with chronic lymphocytic leukemia

Clinical Microbiology Newsletter

Volumn 28, Issue 14, 2006, Pages 110-112

  Hanieh, S ^a   Miller, R ^a   Daveson, L ^a   Oman, K ^a   Norton, R ^a  

^a TOWNSVILLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; COTRIMOXAZOLE; DEXAMETHASONE; IMMUNOGLOBULIN; MEROPENEM; METRONIDAZOLE; PREDNISONE; VORICONAZOLE;

ADULT; ANAMNESIS; ARTICLE; BIOPSY; BLOOD CULTURE; CANCER PATIENT; CANCER STAGING; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLADOPHIALOPHORA BANTIANA; CLADOSPORIUM; COMPUTER ASSISTED TOMOGRAPHY; DROWSINESS; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; MYCOSIS; PHAEOHYPHOMYCOSIS; PHYSICAL EXAMINATION;

EID: 33745480584     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2006.06.005     Document Type: Article

References (12)

1. Revankar S., Sutton D.A., and Rinaldi M.G. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin. Infect. Dis. 38 (2004) 206-216
2. Binford C.H., Thompson R.K., and Gorhan M.E. Mycotic brain abscess due to C. trichoides, a new species: report of a case. Am. J. Clin. Pathol. 22 (1952) 535-542
3. Brandt M.E., and Warnock D.W. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J. Chemother. 15 (2003) 36-47
4. Kantarcioglu A., and de Hoog G.S. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 47 (2004) 4-13
5. Crichlow D.K., Enrile F.T., and Memon M.Y. Cerebellar abscess due to Cladophialophorum bantianum: case report. Am. J. Clin. Pathol. 60 (1973) 416
6. Osiyemi O., et al. Cerebral phaeohyphomycosis due to a novel species: report of a case and review of the literature. Transplantation 71 (2001) 1343-1346
7. Walsh T.H., and Groll A.H. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transplant Infect. Dis. 1 (1999) 247-261
8. Johnson L.B., and Kauffman C.A. Voriconazole: a new triazole antifungal agent. Clin. Infect. Dis. 36 (2003) 630-637
9. Johnson E.M., Szekely A., and Warnock D.W. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J. Antimicrob. Chemother. 42 (1998) 741-745
10. Radford S., Johnson E., and Warnock D. In vitro studies of activity of voriconazole (UK - 109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob. Agents Chemother. 41 (1997) 841-843
11. Fica, A. et al. Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana. Scand. J. Infect. Dis. 35:892-893.
12. Trinh J.V., et al. Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy. Med. Mycol. 41 (2003) 339-345